205 related articles for article (PubMed ID: 32641707)
1. ISG15 induces ESRP1 to inhibit lung adenocarcinoma progression.
Qu T; Zhang W; Qi L; Cao L; Liu C; Huang Q; Li G; Li L; Wang Y; Guo Q; Guo Y; Ren D; Gao Y; Wang J; Meng B; Zhang B; Cao W
Cell Death Dis; 2020 Jul; 11(7):511. PubMed ID: 32641707
[TBL] [Abstract][Full Text] [Related]
2. Epithelial Splicing Regulatory Protein 1 Inhibits the Invasion and Metastasis of Lung Adenocarcinoma.
Li L; Qi L; Qu T; Liu C; Cao L; Huang Q; Song W; Yang L; Qi H; Wang Y; Gao B; Guo Y; Sun B; Meng B; Zhang B; Cao W
Am J Pathol; 2018 Aug; 188(8):1882-1894. PubMed ID: 29803834
[TBL] [Abstract][Full Text] [Related]
3. ESRP1 as a prognostic factor of non-small-cell lung cancer is related to the EMT transcription factor of Twist.
Cui J; Ren P; Li Y; Ma Y; Wang J; Lin C; Jing L; Tong X; Ma S; Chen J
Thorac Cancer; 2021 Sep; 12(18):2449-2457. PubMed ID: 34342121
[TBL] [Abstract][Full Text] [Related]
4. ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling.
Zheng M; Niu Y; Bu J; Liang S; Zhang Z; Liu J; Guo L; Zhang Z; Wang Q
Aging (Albany NY); 2021 Jan; 13(3):3554-3572. PubMed ID: 33495408
[TBL] [Abstract][Full Text] [Related]
5. A negative feedback of the HIF-1α pathway via interferon-stimulated gene 15 and ISGylation.
Yeh YH; Yang YC; Hsieh MY; Yeh YC; Li TK
Clin Cancer Res; 2013 Nov; 19(21):5927-39. PubMed ID: 24056783
[TBL] [Abstract][Full Text] [Related]
6. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
[TBL] [Abstract][Full Text] [Related]
7. SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-I inhibitors via induction of ISG15.
Tessema M; Yingling CM; Thomas CL; Klinge DM; Bernauer AM; Liu Y; Dacic S; Siegfried JM; Dahlberg SE; Schiller JH; Belinsky SA
Oncogene; 2012 Sep; 31(37):4107-16. PubMed ID: 22158045
[TBL] [Abstract][Full Text] [Related]
8. ISG15 targets glycosylated PD-L1 and promotes its degradation to enhance antitumor immune effects in lung adenocarcinoma.
Qu T; Zhang W; Yan C; Ren D; Wang Y; Guo Y; Guo Q; Wang J; Liu L; Han L; Li L; Huang Q; Cao L; Ye Z; Zhang B; Zhao Q; Cao W
J Transl Med; 2023 May; 21(1):341. PubMed ID: 37217923
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of interferon-stimulated gene 15 and its conjugation machinery, UbE1L and UbcH8 expression by tumor necrosis factor-α through p38 MAPK and JNK signaling pathways in human lung carcinoma.
Lertsooksawat W; Wongnoppavich A; Chairatvit K
Mol Cell Biochem; 2019 Dec; 462(1-2):51-59. PubMed ID: 31428903
[TBL] [Abstract][Full Text] [Related]
10. Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT.
Harvey SE; Xu Y; Lin X; Gao XD; Qiu Y; Ahn J; Xiao X; Cheng C
RNA; 2018 Oct; 24(10):1326-1338. PubMed ID: 30042172
[TBL] [Abstract][Full Text] [Related]
11. The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial-mesenchymal transition in resected lung adenocarcinoma.
Matsubara T; Toyokawa G; Takada K; Kinoshita F; Kozuma Y; Akamine T; Shimokawa M; Haro A; Osoegawa A; Tagawa T; Mori M
PLoS One; 2019; 14(5):e0215103. PubMed ID: 31042721
[TBL] [Abstract][Full Text] [Related]
12. Protein ISGylation and free ISG15 levels are increased by interferon gamma in breast cancer cells.
Tecalco-Cruz AC; Cruz-Ramos E
Biochem Biophys Res Commun; 2018 May; 499(4):973-978. PubMed ID: 29626479
[TBL] [Abstract][Full Text] [Related]
13. RBM10 inhibits cell proliferation of lung adenocarcinoma via RAP1/AKT/CREB signalling pathway.
Jin X; Di X; Wang R; Ma H; Tian C; Zhao M; Cong S; Liu J; Li R; Wang K
J Cell Mol Med; 2019 Jun; 23(6):3897-3904. PubMed ID: 30955253
[TBL] [Abstract][Full Text] [Related]
14. ISG15 in cancer: Beyond ubiquitin-like protein.
Han HG; Moon HW; Jeon YJ
Cancer Lett; 2018 Dec; 438():52-62. PubMed ID: 30213559
[TBL] [Abstract][Full Text] [Related]
15. RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma.
Zhang Y; Sun L; Gao X; Guo A; Diao Y; Zhao Y
BMC Cancer; 2019 Jul; 19(1):670. PubMed ID: 31286874
[TBL] [Abstract][Full Text] [Related]
16. Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT.
Vadlamudi Y; Dey DK; Kang SC
Curr Cancer Drug Targets; 2020; 20(9):654-665. PubMed ID: 32564755
[TBL] [Abstract][Full Text] [Related]
17. Interferon-stimulated gene 15 modulates cell migration by interacting with Rac1 and contributes to lymph node metastasis of oral squamous cell carcinoma cells.
Chen YL; Wu WL; Jang CW; Yen YC; Wang SH; Tsai FY; Shen YY; Chen YW
Oncogene; 2019 Jun; 38(23):4480-4495. PubMed ID: 30765861
[TBL] [Abstract][Full Text] [Related]
18. Interferon-stimulated gene 15 and ISGylation are upregulated in glioblastoma.
Tecalco-Cruz AC; Velasco-Loyden G; Robles-Villarruel L; Cortes-González CC; Zepeda-Cervantes J; Pineda B; Chagoya de Sánchez V
Biochem Biophys Res Commun; 2022 Sep; 621():144-150. PubMed ID: 35834923
[TBL] [Abstract][Full Text] [Related]
19. CircRNA has_circ_0006427 suppresses the progression of lung adenocarcinoma by regulating miR-6783-3p/DKK1 axis and inactivating Wnt/β-catenin signaling pathway.
Yao Y; Hua Q; Zhou Y
Biochem Biophys Res Commun; 2019 Jan; 508(1):37-45. PubMed ID: 30470570
[TBL] [Abstract][Full Text] [Related]
20. ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment.
Chen L; Sun J; Meng L; Heathcote J; Edwards AM; McGilvray ID
J Gen Virol; 2010 Feb; 91(Pt 2):382-8. PubMed ID: 19846672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
